Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Federal Health Regulators Release Lightly Redacted Theranos Report with More Details

April 27, 2016By Alex Keown, Breaking News Staff   PALO ALTO, Calif. – Embattled Theranos has repeatedly failed to meet federal guidelines for blood-testing labs despite being granted extra time to address the failures, a letter from the U.S. Centers for Medicare and Medicaid Services (CMMS) that was recently made public revealed. The lightly […]

Read More »

Anavex’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response

April 27, 2016By Mark Terry, Breaking News Staff   New York-based Anavex Life Sciences Corp. (AVXL)’s stock popped about 23 percent after two promising anecdotes about patients receiving its Alzheimer’s drug, Anavex 2-73, were reported. Anavex’s drug, Anavex 2-73, is being administered to Alzheimer’s patients in Sydney, Australia as part of a Phase II […]

Read More »

Valeant CEO to tell Senate he regrets raising heart drug prices

Outgoing Valeant Pharmaceuticals (VRX.TO) Chief Executive Michael Pearson plans to tell a U.S. Senate panel on Wednesday that he regrets his decision to acquire and jack up the price of two life-saving heart drugs, saying it was all a “mistake.”   “The company was too aggressive- and I, as its leader, was too aggressive – […]

Read More »

WHO issues yellow fever warning as deadly outbreak grows

Amid rising concern over a deadly outbreak of yellow fever spreading from Angola, the World Health Organization on Tuesday urged travelers to the African country to heed its warnings and get vaccinated. At least 258 people have been killed and there have been around 1,975 suspected cases of the mosquito-borne disease since an epidemic erupted […]

Read More »

FDA Panel Votes Against Sarepta’s DMD Drug

The U.S. FDA’s PCNSC voted against a recommendation for Sarepta Therapeutics’ eteplirsen for Duchenne Muscular Dystrophy (DMD).

Read More »

ImmunoGen Taps Former Shire Exec as New CEO

Mark Enyedy, a former executive vice president at Shire Plc , will take over ImmunoGen Inc. as the company’s next president and chief executive officer.

Read More »

AstraZeneca sells U.S. gout drug rights to Ironwood for up to $265 million

AstraZeneca Plc said Ironwood Pharmaceuticals Inc. would buy the U.S. marketing rights for its newly approved gout drug for up to $265 million.

Read More »

Zymeworks, GSK Enter Second Strategic Collaboration for Bi-Specific Antibodies

Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies   VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc., a leader in the development of bi-specific and multi-specific antibodies and antibody drug conjugates, announced today that it has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific […]

Read More »

First year in daycare may be prime time for stomach bugs

Kids starting daycare may be at increased risk of stomach bugs during the first year but then have few infections later on, according to researchers in The Netherlands. The results suggest that daycare may ultimately protect children from stomach infections over time. So-called acute gastroenteritis is an important cause of illness and doctor visits in developed […]

Read More »

Canada confirms its first sexually transmitted Zika case

An Ontario resident is Canada’s first confirmed case of a Zika virus infection that was contracted locally through sex, health officials said on Monday.   The individual, who was not further identified, is believed to have contracted the virus from a sexual partner who came down with Zika after traveling to an affected country, according […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom